Cita APA

Graybill, W. S., Pardo Búrdalo, B., O’Malley, D. M., Vergote, I., Monk, B. J., Auranen, A., . . . Stockman, L. (2024). Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.

Citación estilo Chicago

Graybill, Whitney S., et al. Predictors of Long-term Progression-free Survival in Patients With Ovarian Cancer Treated With Niraparib in the PRIMA/ENGOT-OV26/GOG-3012 Study. 2024.

Cita MLA

Graybill, Whitney S., et al. Predictors of Long-term Progression-free Survival in Patients With Ovarian Cancer Treated With Niraparib in the PRIMA/ENGOT-OV26/GOG-3012 Study. 2024.